Thousands invited to participate in landmark cancer study

In a groundbreaking initiative, 16,000 people in Iceland have been invited to take part in a major study on quality of life after cancer.

According to a statement from the Icelandic Cancer Society, this is the country's largest study of its kind. Its goal is to gather vital insights into the lives of cancer survivors and the long-term effects of the disease and its treatment.

"Following a cancer diagnosis and treatment, many individuals experience lasting effects such as sensory disturbances, infertility, chronic fatigue, and musculoskeletal issues, among others. This study aims to deepen our understanding of these challenges to develop better treatments and support systems to improve people’s lives," the statement explains.

The study is being conducted by the Icelandic Cancer Society in collaboration with Landspítali, the University of Iceland, and an international research partner. Participants will include individuals diagnosed with cancer in the past decade, as well as a comparison group from the general population.

One in three Icelanders will face cancer

Currently, one in three Icelanders will be diagnosed with cancer at some point in their lives. However, survival rates have significantly improved—three out of four patients now survive, double the rate from 50 years ago. Advances in early detection and treatment are expected to further increase life expectancy.

There are approximately 18,500 cancer survivors in Iceland today, and this number is steadily growing. Despite this progress, little is known about the long-term experiences of those who have completed treatment. Many live with chronic or late-onset side effects and require better support than is currently available.

By enhancing resources and care, more cancer survivors can enjoy a higher quality of life, and society as a whole can benefit from their continued contributions.